INDUSTRY OPPORTUNITIES OVERVIEW

INDUSTRY OPPORTUNITIES

The EACTS Annual Meeting is the largest event for the cardiothoracic community, attracting several thousand delegates. It provides the perfect forum to promote your products and services to the world’s leading cardiothoracic surgeons as well as physicians in related specialties, residents and allied health professionals. 

 

In addition to our large Exhibition we will be offering a range of other sponsorship opportunities to our Industry partners participating in at the 2023 Annual Meeting in Vienna.  Further details will be shared soon – if you would like to be included in receiving these, please contact industry@eacts.co.uk.

SATELLITE SYMPOSIA

The following companies will be organising satellite symposia during the 36th Annual Meeting. These sponsored programmes do not form part of the official scientific programme of EACTS. By attending these sessions, please be aware that you will be giving permission for your personal details to be shared with the company holding the symposium.

 

Thursday 6th October, 12:45-14:00

Date: Thursday 6 October
Time: 12:45-14:00
Room: Amber 5

Website

Innovative strategies for superior outcome in Cardiac Surgery including pMCS support in therapy pathway

Chairs: Professor Hermann Reichenspurner (Hamburg, Germany), Professor Roberto Lorusso (Maastricht, Germany)

Prevention of PCCS in high-risk Cardiac Surgery patients by elective implant of pMCS
Dr. Assad Haneya (Kiel, Germany)

Structural heart disease – innovative approaches extending therapy scope by using pMCS support
Dr. Bastian Schmack (Essen, Germany)

Tailored solutions to treat advanced CGS patients combining ECMO with pMCS
Professor Evgenij Potapov (Berlin, Germany) 

Date: Thursday 6 October
Time: 12:45-14:00
Room: Botticelli
Contact: Jane Bettoni – Jane.Bettoni@artivion.com

Website

Beyond the hemiarch: a simple therapy for Acute Type A Dissections

Moderators: Professor Benussi (Brescia, Italy), Professor Oo (London, UK)

3-Year Outcomes of the Dissected Aorta Repair Through Stent Implantation Trial
Dr M. Moon (Edmonton, Canada)

The arch remodelling stent for DeBakey 1 AAD: experience with 100 implantations
Dr M. Montagner (Berlin, Germany)

Early results of a novel hybrid prosthesis for treatment of AATAD with distal anastomosis beyond zone 0
Prof P. Akhyari (Achen, Germany)

How to introduce a new therapeutic approach in the acute setting
Mr R. De Silva (Cambridge, UK)

Date: Thursday 6 October
Time: 12:45-14:00
Room: Amber 4
Contact: salessupportEU@atricure.com

Website

A patient-centric approach for AF treatment

Chairs: Richard Whitlock M.D., Ph.D., McMaster University (Hamilton, Canada), Carlo De Asmundis M.D., Ph.D, Universitair Ziekenhuis (Brussels, Belgium)

Who should be treated in 2022?
Richard Whitlock M.D., Ph.D., McMaster University (Hamilton, Canada)

Meet-my-patients roundtable (patient cases presentations)
– Concomitant Surgical Ablation + LAA: Mark La Meir M.D., Ph.D., Universitair Ziekenhuis (Brussels, Belgium)
Hybrid case + LAA: Thorsten Hanke MD., Ph.D., Asklepios Klinikum Harburg (Hamburg, Germany)
– LAA management: Stefano Branzoli M.D., Ospedale S. Chiara (Trento, Italy)

Closing remarks: there is a solution for all AF patients
Richard Whitlock M.D., Ph.D., McMaster University (Hamilton, Canada)

Date: Thursday 6 October
Time: 12:45-14:00
Room: Amber 1 & 2
Contact: Anne Chafii-Jaguello, Infection Prevention Marketing Manager (EMEA) – Anne.Chafii-Jaguello@bd.com

Website

Surgical Site Infections in cardiac surgery: optimizing prevention measures

Chair: Professor Menicanti

Speakers: Prof Petrosillo & Mr Lucchese

Date: Thursday 6 October
Time: 12:45-14:00
Room: Brown 3
Contact: Sonia Hennou (Dir, Professional Ed and Medical Affairs) Sonia_Hennou@edwards.com; Florian Novat (Manager, Professional Education and Medical Affairs) Florian_Novat@edwards.com

Website

State of the art in the treatment of aortic valve regurgitation in young patients

Chairs: Torsten Doenst, Ruggero De Paulis

When there is a disconnect between guidelines and patient wishes, the importance of individualized care
Torsten Doenst

Aortic regurgitation: the importance of early referral and anatomical assessment
Ruggero De Paulis

Management of aortic regurgitation: gaps, current evidences and future options
Thomas Senage

Assessment of a new bioprosthetic valve to treat young patients with bicuspid aortic valve
Siamak Mohammadi

Panel Discussion

Date: Thursday 6 October
Time: 12:45-14:00
Room: Amber 3
Contact: Carolin Thiery – c.thiery@koehler-chemie.de

Website

Mission (Im)Possible – Four Cornerstones for Success in Cardiac Surgery

Chairs: Friedhelm Beyersdorf (Freiburg), Jochen Cremer (Kiel)

Personalized Indication – why not a complex surgical procedure in a frail octogenarian?
Milan Milojevic (Rotterdam)

Importance of Surgical Technique – Consequences of imperfect surgical results beyond the direct injury
Jolanda Kluin (Amsterdam)

Organ Protection & Cardioplegic Solutions – Do we have the fi nal insight into the problem?
Serdar Gunaydin (Ankara)

Perioperative Cellular Protection – “Failure to prepare is preparing to fail”
Friedhelm Beyersdorf (Freiburg)

Date: Thursday 6 October
Time: 12:45-14:00
Room: Michelangelo

Website

Cardiac Surgery time machine: Get ready for the future!

Chairs: Prof. Pieter Kappetein, Prof. Joerg Kempfert

Welcome on board
Prof. Kempfert, Prof. Kappetein 

The acceleration of clinical knowledge. Real world data or still controlled studies?
Prof. Meuris

TAVI are now used in patients of all surgical risks. Are you on board?
Prof. Modine

Lifetime management and patient longevity, what is the best patient scenario?
Prof. Borger

Do we still perform sternotomy, or it is now all MICS?
Prof. Pitsis 

When there is equality, we all thrive! Removing the barriers to diversity and inclusion in Cardiac Surgery.
Dr. Rashmi Yadav

Final discussion and closure
Prof. Kappetein, Prof. Kempfert

Date: Thursday 6 October
Time: 12:45-14:00
Room: Brown 1
Contact: Anne Waaler – anne.waaler@medistim.com

Website

Routine Quality Assessment in CABG and Aortic surgery

Moderator: Professor John Puskas (New York)

Expert recommendations for TTFM use
Mario Gaudino (New York)

CABG cases – How to interpret TTFM
David Glineur (Ottawa)

Aortic cases – Why is epiaortic ultrasound guidance important?
Konstantinos Tsagakis (Essen)

TTFM and HFUS in  CABG – interactive case discussion
John Puskas (New York) & David Taggart (Oxford)

Q&A

Date: Thursday 6 October
Time: 12:45-14:00
Room: Brown 2
Contact: info@resuscitec.de

Website

CARL. Controlled Automated Reperfusion of the whoLe body – A new concept treating patients with cardiac arrest

Chairs: Frederico Pappalardo (Alessandria), José Luis Pomar (Barcelona)

Scientific background to CARL Therapy – The new kid in town
Jan-Steffen Pooth (Freiburg)

Implementation of CARL – Never walk alone
Hug Aubin (Düsseldorf )

Preparation for CARL Therapy – Just Do It
Christoph Benk (Freiburg)

Shifting the limits of resuscitation – Latest multicenter clinical results
Georg Trummer (Freiburg)

Round Table Discussion

Thursday 6th October, 18:00-19:15

Date: Thursday 6 October
Time: 18:00-19:15
Room: Amber 4
Contact: Elad Harf – elad.harf@graftsolutions.com

Website

Bright future for vein grafts: techniques and technologies to improve the clinical outcome of CABG

Preclinical evidence of the biomechanical effects of external vein graft support
Prof. Peter Zila

The bio mechanical effect of external support and applications
Prof. David P Taggart

Randomized controlled data of VEST external stent
Prof. Nikolaos Bonaros

Improved clinical outcome of CABG with external stent – real world evidence
Prof. Luca P Weltert

Friday 7th October, 12:45-14:00

Date: Friday 7 October
Time: 12:45-14:00
Room: Brown 2
Contact: infoEMEA@abbott.com

Website

From Established to Advanced Heart Failure Therapies and Technologies that Change Lives

Chairs: Mariano Feccia (Italy) & Francesco Maisano (Italy) 

Welcome and Introduction
Mariano Feccia (Italy) & Francesco Maisano (Italy)

Surgical Mitral Valve Repair vs Replacement in the Modern Era of Transcatheter Valve Interventions
Joerg Kempfert (Germany)

When can Tendyne™ TMVR be a relevant substitute for on-pump MVR
Rüdiger Lange (Germany)

HeartMate 3™ LVAD positioning and implications for patient outcomes
Dominik Wiedemann (Austria)

5-year survival with LVAD Therapy in MOMENTUM 3
Sern Lim (United Kingdom)

Round table discussion and closing

Date: Friday 7 October
Time: 12:45-14:00
Room: Amber 3
Contact: Jane Bettoni – Jane.Bettoni@artivion.com

Website

Choosing the most appropriate treatment option for arch pathologies

Moderators: Professor Shrestha (Rochester, USA), Professor Grabenwöger (Vienna, Austria)

Transition from Evita Open Plus to Evita Open NEO – The West German Heart Center (Essen) Experience
Dr K. Tsagakis (Essen, Germany)

Evita Open NEO in acute aortic dissections
Dr D. Dohle (Mainz, Germany)

Decision algorithm for DeBakey type 1 AAD
Mr R. De Silva (Cambridge, UK)

Endovascular aortic arch repair with Nexus: technical insights and 3-year outcomes
Prof. A. D’Onofrio (Padova, Italy)

Date: Friday 7 October
Time: 12:45-14:00
Room: Amber 4
Contact: Kristin von Hammerstein – Kristin.vonHammerstein@cytosorbents.com

Website

Hemoadsorption with CytoSorb in high-risk cardiac surgery indications – new data

Chair: Guillaume Lebreton (Paris, France), Piotr Suwalski (Warsaw, Poland)

Removal of antithrombotic drugs to reduce bleeding complications and costs in high urgency operations
Michael Schmoeckel (Hamburg, Germany)

Clinical benefits in patients undergoing heart transplantation – results of a single center RCT
Endre Németh (Budapest, Hungary)

CytoSorb in infective endocarditis patients – what can we learn from recent data?
Matthias Thielmann (Essen, Germany)

Date: Friday 7 October
Time: 12:45-14:00
Room: Brown 3
Contact: Sonia Hennou (Dir, Professional Ed and Medical Affairs) Sonia_Hennou@edwards.com; Florian Novat (Manager, Professional Education and Medical Affairs) Florian_Novat@edwards.com

Website

Aortic valve disease: Patient centric management in elderly population

Chairs: Marjan Jahangiri, Vinod Thourani 

Management of aortic valve diseases: what do the guidelines indicate for patients over the age of 65?
Matthias Siepe

Not all biological valves are equal: a single-center experience
Amedeo Anselmi

Burden of degenerated TAVI: which therapeutic approach?
Vinod Thourani

Enhanced Recovery After Cardiac Surgery in elderly population: benefits of a multi-modal approach
Jan Gummert

Panel Discussion

Date: Friday 7 October
Time: 12:45-14:00
Room: Michelangelo

Website

Top secrets you need to know for your success in SAVR

Chairs: Prof. Reichenspurner (Germany), Prof. Günther Laufer (Austria)

Welcome on board
Prof. Reichenspurner (Germany), Prof. Günther Laufer (Austria)

Revealing Avalus top secret. Let us discover what makes it unique!
Dr. De Raet (Belgium )

Avalus hemodynamics at its best! 
Dr. Hwang (Korea)

Avalus real world evidence: first results of 300+ patients!  
Prof. Verbelen (Belgium)

Avalus in younger patients (< 65). Real world experience and clinical evidence.
Dr. Greco (UK)

When size matters, choose Avalus! Largest internal diameter and opening reserve.
Mr. Pousios (UK)

Final discussion and closure
Prof. Reichenspurner (Germany), Prof. Günther Laufer (Austria)

Date: Friday 7 October
Time: 12:45-14:00
Room: Amber 1 & 2
Contact: Lindsay McMaster- l.mcmaster@terumoaortic.com

Website

Thoraflex Hybrid: Gold Standard

Moderator: Professor Roberto Di Bartolomeo

Normotheric approach with FET
Professor Marco De Eusanio

Clinical Data supporting the Gold Standard
Professor Davide Pacini

A new Era for FET in the US
Professor Joseph Coselli

Hybrid technology addressing Thoracoabdominal Challenges
Professor Sabine Wipper

Saturday 8th October

The European Board of Cardiovascular Perfusion

Date: Saturday 8 October
Room: Raphael

Website

EBCP Annual Meeting / 22nd EcOPEaT / Milan 08/10/2022

 

EcOPEaT Symposium Details

The 36th EACTS Annual Meeting has been registered as COMPLIANT by MedTech.

Exhibitor List 2022

The EACTS trade exhibition is an important and most time efficient way to keep up to date with new to market technology, state of the art products, innovations and developments in the cardiothoracic market.  The exhibiting companies are looking forward to meet the people that matter to their business in one place, demonstrate new products and attract interest from new prospects and existing customers.

The support of our industry partners is important. As we develop more flexible and innovative ways to communicate and share educational content, we are excited to offer new engagement opportunities for our industry partners.

We look forward to working with you.  For full details and pricing, please contact industry@eacts.co.uk

INDUSTRY OPPORTUNITIES OVERVIEW

INDUSTRY OPPORTUNITIES

The EACTS Annual Meeting is the largest event for the cardiothoracic community, attracting several thousand delegates. It provides the perfect forum to promote your products and services to the world’s leading cardiothoracic surgeons as well as physicians in related specialties, residents and allied health professionals. 

 

In addition to our large Exhibition we offer a range of other sponsorship opportunities to our Industry partners participating in this year’s Annual Meeting in Milan.  For further details please contact industry@eacts.co.uk

The 36th EACTS Annual Meeting has been registered as COMPLIANT by MedTech.

Exhibitor List 2021

The EACTS trade exhibition is an important and most time efficient way to keep up to date with new to market technology, state of the art products, innovations and developments in the cardiothoracic market.  The exhibiting companies are looking forward to meet the people that matter to their business in one place, demonstrate new products and attract interest from new prospects and existing customers.

The support of our industry partners is important. As we develop more flexible and innovative ways to communicate and share educational content, we are excited to offer new engagement opportunities for our industry partners.

We look forward to working with you.  For full details and pricing, please contact industry@eacts.co.uk

Francis Fontan Fund Fellowships: Open for Applications Now

Francis Fontan Fund Fellowships: Open for Applications Now until mid-end Sep 2021

Fellowship scheme
EACTS members can now apply for a prestigious Francis Fontan Fund Fellowship. A wide variety of Fellowship schemes are available to members around the world with the aim of supporting surgical education, fostering professional development and strengthening the global cardiothoracic community through increased knowledge share.

The Fellowship programme offers unique career opportunities across a range of cardio and thoracic surgical experiences, with access to world-class courses, residential training in both European and American centres of excellence and clinical proctorship with surgical leaders. The Fund represents a vital part of the EACTS’ educational offering.

Professor Rafael Sádaba, EACTS Secretary General & Chairman of the Francis Fontan Fund, says: “The Fund’s mission is to create a global community sharing and learning from the highest standards of cardiothoracic care. Our Fellows are given the tools to establish life-saving new techniques in their institution and to emerge with skills, techniques and supportive professional networks that they could not have gained in any other way.”

The Fund offers three categories of Fellowship: Research, Leadership and Education. Research Fellowships offer experienced cardiothoracic surgeons a placement in cardiothoracic research, whilst Leadership Fellowships enable candidates to attend specialist courses and a placement in a clinic specialised in a specific area of cardiothoracic surgery. Education Fellowships offer candidates early in their surgical career foundation knowledge in a specific aspect of cardiothoracic surgery.

There are four Fellowship programmes that are now open for EACTS member to apply. Please note the application deadlines below, it is essential that you do not submit a late submission.

1. TSF/FFF International Travelling Fellowship 2022

Application Deadline: 15 Sep 2021

The European Association for Cardio-Thoracic Surgery and The Society of Thoracic Surgeons have collaborated to offer the TSF/FFF International Travelling Fellowship. This new Fellowship offers young faculty surgeons an exciting opportunity to travelto America and learn from surgeons dedicated to the highest standards of cardiothoracic care.

Click here for further information and to apply.

2. EACTS-MSTCVS Quality and Outcomes Fellowship 2022

Application Deadline: 29 Sep 2021

This Fellowship provides an in-depth understanding of cardiothoracic surgical outcomes with one of the world’s leading quality improvement teams, based in Ann Arbor, Michigan.

Click here for further information and to apply.

3. Off-Pump Coronary Artery Bypass Fellowship 2022

Application Deadline: 29 Sep 2021

Available to newly graduated cardiothoracic surgeons from around the world, this Fellowship offers an educational opportunity to enhance clinical understanding and acquire theoretical and practical knowledge in the surgical management of patients with coronary artery disease.

Click here for further information and to apply

4. Advanced Intensive Postoperative Care 2022

Application Deadline: 29 Sep 2021

This Fellowships offers an opportunity to gain experience in the postoperative management in adult cardiovascular surgery, as well as a wide exposure to minimally invasive and other advanced techniques in cardiovascular surgery.

Click here for further information and to apply.

EACTS is saddened by the loss of Hans Huysmans on 25 August 2021.

Hans Huysmans (1933-2021) 

EACTS is saddened by the loss of Hans Huysmans on 25 August 2021. Professor Hans Huysmans was one of the founding fathers of our Association. 

Hans was born into a family of doctors and started his career in general surgery. As a general surgeon he performed thoracic and also some cardiac procedures. He was then appointed as a professor of cardiothoracic surgery in Utrecht, the Netherlands. This was in the early days of heart surgery and our specialty was struggling to become a discipline that was independent of general surgery. In 1979 Hans switched to Leiden University where he was appointed as Gerard Brom’s successor. Professor Huysmans remained head of the department of cardiothoracic surgery in Leiden until 1998. 

Hans Huysmans has contributed much of his energy to the development of cardiothoracic surgery as an independent specialty, not only in his home country but also at a European level. Apart from being one of the founding members he was EACTS president from 1989-1990. Hans worked particularly hard to create a robust training programme for EACTS. The European Board of Thoracic and Cardiovascular Surgery (EBTCS) was founded in 1995 and is now a well-respected training programme with examinations in all different subspecialties of cardiothoracic surgery. 

Personally, I was accepted by him as a trainee in cardiothoracic surgery in Leiden, something that I have never regretted. Hans Huysmans was a technically gifted and universal surgeon with an endless patience for his residents. He supported his trainees as much as he could and was always friendly. Until the very end Hans continued to show a keen interest in our specialty. We will miss him and wish Anne-Marie and his family our sincere condolences and best wishes. 

Mark Hazekamp, President, EACTS 

Guidelines for the management of valvular heart disease

31 August 2021

The European Association for Cardio-Thoracic Surgery (EACTS) and European Society of Cardiology (ESC) Guidelines for the management of valvular heart disease were published online in the European Journal of Cardio-Thoracic Surgery on Saturday 28th of August 2021.

EACTS is proud of this collaborative joint guideline, including all members of the Heart Team. A discussion within the Heart Team should be the basis of all treatment decisions. This recommendation should be discussed with the patient, who can then make an informed decision.

We recognise there is considerable interest in the use of age cut-offs to assist in the choice of intervention for aortic stenosis. The evidence favours SAVR in some patients, TAVI in others, and either mode of intervention can be used for those in between. The Heart Team discussion is central in the care of these patients, and the guideline (table 6) details the clinical, anatomical and procedural factors that influence the choice of treatment modality for an individual patient.

Randomised controlled trials comparing SAVR to TAVI have included patients based on estimated risk, not age, and there has been no evidence of interaction between age and outcomes. Life expectancy for an individual patient is difficult to estimate; it varies widely across the world and is dependent on absolute age, sex, frailty, and the presence of comorbidities. Age was chosen as surrogate, considering the interplay between estimated life expectancy and prosthetic heart valve durability.

Despite the lack of evidence for age in determining intervention modality, it has been used in several other recent recommendations. The 2017 ESC/EACTS valvular heart disease guidelines already proposed an age limit of 75 as cut-off (in table 7). The ACC/AHA 2020 guidelines recommend TAVR >80, SAVR <65 and a Heart Team discussion for patients in between. The German Cardiology and Cardiac Surgery Associations’ consensus statement proposes SAVR for low-risk patients ≤70, TAVI for patients ≥75, and a Heart Team discussion for patients in between. The age cut-offs agreed-upon in the ESC/EACTS guidelines can be considered conservative in comparison and were the subject of intense and constructive discussions. As there are no new data regarding age since the 2017 ESC/EACTS guideline, the same age of 75 years was used as in the previous iteration.

The guidelines have advanced other areas. Increased experience and procedural safety have led to expanded indications toward earlier surgery in asymptomatic patients with aortic stenosis, aortic regurgitation and mitral regurgitation. Furthermore, these joint guidelines inaugurated the contribution of a methodology group. We are encouraged to expand the use of this group to all guidelines and putting into place an open process, with independent review of the evidence using validated tools such as the GRADE system, and avoiding conflicts of interest.

We look forward to a continuing fruitful collaboration on these joint guidelines with our colleagues from ESC, advancing a common European perspective on the evidence. These guidelines should be a living document, updated as new data is made available with longer follow-up, particularly in the low-risk trials.

A video summary of advances in these guidelines can be seen on ESC TV (https://www.youtube.com/watch?v=Gb85wvcbWBs), as well as the live session at ESC Congress (for registered users: https://bit.ly/3DuIQCC). A session with Heart Team members of the Taskforce will provide insight during the 35th EACTS Annual Meeting in Barcelona on October 14th

Rafael Sádaba, EACTS Secretary General

Friedhelm Beyersdorf, Chair of the EACTS Task Force for the ESC/EACTS Guidelines on Heart Valve Disease

Highest ever Impact Factor for EACTS journals

13 July 2021

EACTS journals achieved their highest ever Impact Factors in 2020, according to new data published this July by global analytics firm Clarivate. 

The Impact Factor (IF) is a metric that represents the average number of citations in a particular year for articles published in the two previous years. It is an established indicator of the importance or rank of a journal.  

 Rafa Sadaba, EACTS’ Secretary General, said: “We are delighted that our journals have reached their highest ever Impact Factors. This achievement reflects the quality of their scientific content and our authors’ significant influence on advances in cardiothoracic surgery. 

“We hope these journals will have an even greater impact in the future. I encourage surgeons to submit their papers to our journals so that we can continue to advance our collective expertise and improve outcomes for patients.”  

EJCTS’ 2020 Impact Factor is 4.191, a substantial increase from 3.486 in 2019.  The 2020 Impact Factor for ICVTS is 1.905, up from 1.675 last year.  

  • European Journal of Cardio-Thoracic Surgery is a subscription journal.  As a member of EACTS you will automatically have full access to all content.
  • Interactive CardioVascular and Thoracic Surgery is now Open Access and is free to read without a subscription.
  • More information on EACTS journals is here

 

EACTS News – June edition out now!

Welcome to the new EACTS NEWS!

We have launched a new look EACTS News, the quarterly member newsletter that keeps members up to date with the latest news and developments at EACTS.

The reintroduction of EACTS News, now in this digital only format, is part of our commitment to communicate better with our members.

We have much positive news to report. In this issue, you can find out more about:

 

Happy reading!

To learn more about EACTS educational programmes and events Sign-up to receive EACTS email

Vacancy – Publications Director

PUBLICATIONS DIRECTOR
Circa £50,000pa full-time, permanent

EACTS, Windsor, UK.

The European Association for Cardio-Thoracic Surgery is Europe’s largest and leading membership Society for surgeons, perfusionists and health care professionals involved in cardiothoracic care and treatments. We are active in more than 50 countries worldwide and boast an engaged membership of 4,000.

Over the coming years, we will be growing the reach, impact and influence of the Association globally and our publications portfolio is a key element in our planning.  We now wish to appoint our first Publications Director to be responsible for the operational activities and strategic development of our two world-leading journals, the EJCTS and the ICTVS.

This role is ideally suited for an ambitious and strategic professional with a meticulous eye for detail. You will have at least a working knowledge of one of the major journal submissions systems such as Editorial Manager or ScholarOne and enjoy excellent time-management, communication and interpersonal skills.  A salary of circa £50,000 plus pension and benefits and a central Windsor based office location are on offer for the ideal candidate with remote, flexible working considered.

Application

Please click on the link below to download the full Candidate Brief including Job Description.

Applications should consist of a full CV and a supporting letter, which should address key aspects of the responsibilities outlined here and the candidate’s personal suitability for the role.

Completed applications should be emailed to:  recruitment@eacts.co.uk
Closing date for applications: 24 September 2021
The appointment will be made subject to satisfactory references.

EACTS COUNCIL NOMINATIONS 2021

2 July 2021

Summary

The Council (also known as the Board of Trustees) is the governing, decision-making body of EACTS.  The Council is made up of up to 15 members who each serve for set terms, in different capacities, acting at all times in the best interests of the Association, our members and ultimately the patients that we serve. Council meets at least four times a year and some members of Council may also serve other Committees or Domains that meet more frequently.

Each Councillor will serve a set term (normally of up to three years) and each year a number of new Councillors are appointed as the terms of current Councillors come to an end. Councillors to be appointed must complete a process of Nomination (detailed below), selection and eventually, ‘election’ by the members at the General Assembly in October 2021.

Vacant Council Positions 2021

This year the following positions* on Council are to be filled.  A job description for each position is available by clicking on the title;

Vice President

Secretary General

Thoracic Disease Domain Chair

Congenital Disease Domain Chair

Councillor at large

The Process of Nomination and Selection

To ensure as fair and transparent a process as possible, EACTS Regulations (part of our governing document) stipulate that a Nominations Committee be established to oversee the Nomination and Selection process.  This year, the Committee is made up as follows;

  • Senior Past President; Marian Zembala (Chairman)
  • Past President: Ruggero De Paulis
  • Immediate Past President: Peter Licht
  • President: Mark Hazekamp
  • Secretary General: Rafa Sádaba

Any EACTS member can nominate a fellow member for a specified role on Council (there is no limit to the number of nominations a member can make). For avoidance of doubt, current Councillors, Domain and Task Force members may nominate, but members of the Nominations Committee may not.

In making a nomination, the person making the nomination must write a letter of support that includes;

  • a summary of the contribution that the person being nominated has made to his/her professional field,
  • the contribution made to the work of EACTS more broadly by the person being nominated, and
  • the skills and experiences the person being nominated will bring to Council and the specific role under consideration.

The person making the nomination should send a digital form of this letter, with a brief Curriculum Vitae of the person being nominated, to the Chair of the Nominations Committee via the dedicated EACTS e-mail address nominations@eacts.co.uk

The closing date for Nominations is 6pm (CET) Friday 6 August 2021.

The Nominations Committee will consider all applications before making a recommendation to the EACTS Council.  Council will make the final decision as to those to be formally presented for election at the EACTS General Assembly on 15 October 2021 (Barcelona).  Those who have nominated candidates will be informed of the outcome of this decision before 15 October and those members to be nominated will also be contacted before the General Assembly voting process.

 

Secretary General

It is most likely that interviews will be held for nominees short-listed by the Nominations Committee for the Secretary General role. These interviews will take place, via Zoom, between 30 August and 10 September 2021.

The member elected to the role of Secretary General will spend one year shadowing the current Secretary General before taking up the post of Secretary General in October 2022.  The Secretary General term is for three years (beginning October 2022), renewable for up to a further two terms of three years (10 years in total).

 

Vice President

The Vice President will be elected in October 2021 with a view to becoming President in October 2022 and serving a final year on Council as Immediate Past President from October 2023.

*In October 2021, two other Councillor positions will also stand for election; the Honorary Treasurer and the Councillor at large (International Representative).  In June 2021, Council co-opted Mr Mark Whiteling to the role of Honorary Treasurer and Mark will stand for election in October 2021. Councillor at large (International Representative) is a role filled through invitation, by Council, to a representative of a sister Association (usually STS). Therefore, nominations will not be considered for these two roles.

EACTS senior leadership update

Rafa Sadaba in lab coat

Secretary General Appointment
We are delighted to announce that Rafael Sádaba has been appointed as EACTS’ Secretary General.

Rafa is a hugely experienced Cardiothoracic Surgeon. He is an Associate Clinical Professor at the University of Navarra and Head of Cardiovascular Research and Innovation at the Navarra Hospital Complex. His research interests have focused on the molecular and cellular basis of heart valve disease.

Rafa Sadaba, EACTS’ Secretary General said:

“The year ahead will see EACTS reconnecting with its members and we will continue to raise standards through education and training. By embracing new ways of learning and new technologies, we will aim to extend our reach to more surgeons worldwide. We look forward to seeing you – either virtually or in person – very soon.”

Since the beginning of the year, Rafa has been guiding the Association and bringing his energy to develop plans for the Annual Meeting. He will remain in the position until at least October.

We would like to thank Domenico Pagano for his service and dedication to EACTS. Domenico stepped down from his role as Secretary General earlier this year.

He has been our Secretary General since 2017 and, during this time, has enriched us all with his personality and approach. We all send Domenico our very best wishes for the future.